 |
|
|
| |
Repeat dosing of the GalNAc-siRNA AB-729 in subjects
with chronic hepatitis B results in robust
and sustained HBsAg suppression
|
| |
| |
EASL International Liver Congress, June 23-26, 2021 JNJ-3989
MF Yuen1, E Berliba2, W Sukeepaisarnjaroen3, S Strasser4, P Tangkijvanich5, J Holmes6, A Leerapun7, A Jucov2, EP Thi8,
P Wattamwar8, M Sofia8, H Sevinsky8, K Gray8, D Antoniello8, T Eley8, G Picchio8, KD Sims8, E Gane9
|
| |
|
|
|
|
|
